Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000591568 | SCV000700582 | likely pathogenic | not provided | 2016-10-27 | criteria provided, single submitter | clinical testing | |
3billion | RCV003313967 | SCV004013814 | likely pathogenic | Cockayne syndrome type 2 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.75). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with ERCC6 related disorder (ClinVar ID: VCV000496904 / PMID: 26749132). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. |